Literature DB >> 28771023

Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus.

Jenna Yager1, John Faragon2, Liam McGuey1, Adam Hoye-Simek1, Zachary Hecox1, Steven Sullivan1, Stefanie Neubert3, Nimish Patel1,3.   

Abstract

Several antiretrovirals (ART) have been coformulated as single tablet regimens (STR). Study objectives were to compare ART and non-ART adherence between STR and multiple tablet regimens (MTR) recipients, determine whether STR independently predicts ART adherence, and determine whether ART adherence influences non-ART adherence. A retrospective cohort study was performed among Upstate New York Veterans' Healthcare Administration (VISN-2) patients from 2000 to 2013. Inclusion criteria were age ≥18 years, human immunodeficiency virus (HIV) infection, receipt of ≥3 ART medications for ≥3 months, and available pharmacy refill records. The two study outcomes were adherence to ART medications and non-ART medications. Adherence was determined with pharmacy refill records that were used to calculate medication possession ratios. Among the 1202 subjects, there were 165 (13.7%) STR and 1037 (86.3%) MTR recipients. Mean ± standard deviation (SD) ART adherence was significantly higher for STR recipients (81.5% ± 15.3%) than MTR recipients (66.1% ± 21.1%), p < 0.001. Use of STR [adjusted odds ratio (aOR): 5.76, 95% confidence interval (CI): 3.84-8.65, p < 0.001] was independently associated with optimal (≥90%) adherence to ART. Mean ± SD non-ART adherence did not differ between STR (78.8% ± 15.6%) and MTR recipients (80.8% ± 16.0%), p = 0.17. Optimal adherence to ART medications (aOR: 2.30, 95% CI: 1.57-3.38, p < 0.001) was independently associated with optimal adherence to non-ART medications. The use of STRs are associated with optimal adherence to ART medications, but not directly associated with adherence to non-ART medications.

Entities:  

Keywords:  HIV; antiretrovirals; medication adherence; single tablet regimen

Mesh:

Substances:

Year:  2017        PMID: 28771023     DOI: 10.1089/apc.2017.0081

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  5 in total

1.  DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence.

Authors:  Margaret M Paschen-Wolff; Aimee N C Campbell; Susan Tross; Tse-Hwei Choo; Martina Pavlicova; Don Des Jarlais
Journal:  AIDS Care       Date:  2019-11-04

2.  Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide.

Authors:  Wing Chow; Prina Donga; Aurélie Côté-Sergent; Carmine Rossi; Patrick Lefebvre; Marie-Hélène Lafeuille; Hélène Hardy; Bruno Emond
Journal:  Patient Prefer Adherence       Date:  2020-11-23       Impact factor: 2.711

3.  A comparison of medication adherence and viral suppression in antiretroviral treatment-naïve patients with HIV/AIDS depending on the drug formulary.

Authors:  Kyung Sun Oh; Euna Han
Journal:  PLoS One       Date:  2021-01-08       Impact factor: 3.240

4.  Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States.

Authors:  Grace A McComsey; Melissa Lingohr-Smith; Rachel Rogers; Jay Lin; Prina Donga
Journal:  Adv Ther       Date:  2021-08-14       Impact factor: 3.845

Review 5.  Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review.

Authors:  Ana Baumgartner; Katarina Drame; Stijn Geutjens; Marja Airaksinen
Journal:  Pharmaceutics       Date:  2020-02-22       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.